Interaction of angiotensin II and the insulin-like growth factor system in vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 2 46-2, 1999, Pages

  Gustafsson, Thomas ^a   Andersson, Peter ^a   Chen, Yun ^a   Magnusson, Jan Olof ^a   Arnqvist, Hans J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Gene expression; Growth; Insulin like growth factor binding protein; Losartan

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; LOSARTAN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG INHIBITION; DRUG POTENTIATION; GENE EXPRESSION REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0032865829     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.2.h499     Document Type: Article

References (36)

1. Anwar, A., and P. Delafontaine. Hypertension increases insulin-like growth factor binding protein-4 mRNA levels in rat aorta. Hypertension 24: 679-685, 1994.
2. Arnqvist, H. J., K. E. Bornfeldt, Y. Chen, and T. Lindstrom. The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metab. Clin. Exp. 44: 58-66, 1995.
3. Berk, B. C., V. Vekshtein, H. M. Gordon, and T. Tsuda. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13: 305-314, 1989.
4. Bornfeldt, K. E., and H. J. Arnqvist. Effect of insulin-like growth factor-I on metabolism in bovine mesenteric arteries. Acta Physiol. Scand. 131: 563-568, 1987.
5. Bornfeldt, K. E., H. J. Arnqvist, and L. Capron. In vivo proliferation of rat vascular smooth muscle in relation to diabetes mellitus insulin-like growth factor I and insulin. Diabetologia 35: 104-108, 1992.
6. Bornfeldt, K. E., H. J. Arnqvist, and G. Norstedt. Regulation of insulin-like growth factor-I gene expression by growth factors in cultured vascular smooth muscle cells. J. Endocrinol. 125: 381-386, 1990.
7. Bornfeldt, K. E., R. A. Gidlof, A. Wasteson, M. Lake, A. Skottner, and H. J. Arnqvist. Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 34: 307-313, 1991.
8. Bourner, M. J., W. H. Busby, Jr., N. R. Siegel, G. G. Krivi, R. H. McCusker, and D. R. Clemmons. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2, IGFBP-2: comparison of its structural and functional properties with IGFBP-1. J. Cell. Biochem. 48: 215-226, 1992.
9. Chen, Y., K. E. Bornfeldt, A. Arner, E. Jennische, U. Malmqvist, B. Uvelius, and H. J. Arnqvist. Increase in insulin-like growth factor I in hypertrophying smooth muscle. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E224-E229, 1994.
10. Cohick, W. S., A. Gockerman, and D. R. Clemmons. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors. J. Cell. Physiol. 157: 52-60, 1993.
11. Daughaday, W. H., and P. Rotwein. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev. 10: 68-91, 1989.
12. Delafontaine, P., and H. Lou. Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J. Biol. Chem. 268: 16866-16870, 1993.
13. Delafontaine, P., H. Lou, and R. W. Alexander. Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension 18: 742-747, 1991.
14. Dubey, R. K., A. Roy, and H. W. Overbeck. Culture of renal arteriolar smooth muscle cells. Mitogenic responses to angiotensin II. Circ. Res. 71: 1143-1152, 1992.
15. Durnam, D. M., and R. D. Palmiter. A practical approach for quantitating specific mRNAs by solution hybridization. Anal. Biochem. 131: 385-393, 1983.
16. Fath, K. A., R. W. Alexander, and P. Delafontaine. Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. Circ. Res. 72: 271-277, 1993.
17. Giannella-Neto, D., A. Kamyar, B. Sharifi, C. J. Pirola, J. Kupfer, R. G. Rosenfeld, J. S. Forrester, and J. A. Fagin. Platelet-derived growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4. Circ. Res. 71: 646-656, 1992.
18. Gustafsson, T., P. Andersson, and H. J. Arnqvist. Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells. J. Endocrinol. In press.
19. Hwang, D. L., L. J. Latus, and A. Lev-Ran. Effects of platelet-contained growth factors (PDGF, EGF, IGF-I, and TGF-beta) on DNA synthesis in porcine aortic smooth muscle cells in culture. Exp. Cell Res. 200: 358-360, 1992.
20. Itoh, H., M. Mukoyama, R. E. Pratt, G. H. Gibbons, and V. J. Dzau. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J. Clin. Invest. 91: 2268-2274, 1993.
21. Kamyar, A., C. J. Pirola, H. M. Wang, B. Sharifi, S. Mohan, J. S. Forrester, and J. A. Fagin. Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells. Circ. Res. 74: 576-585, 1994.
22. Ko, Y., A. Sachinidis, A. J. Wieczorek, M. Appenheimer, R. Dusing, and H. Vetter. Insulin enhances angiotensin II induced DNA synthesis in vascular smooth muscle cells of the rat. Clin. Investig. 71: 379-382, 1993.
23. Ko, Y., H. Stiebler, G. Nickenig, A. J. Wieczorek, H. Vetter, and A. Sachinidis. Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-beta on platelet-derived growth factor-BB, basic fibroblastic growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. Am. J. Hypertens. 6: 496-499, 1993.
24. Labarca, C., and K. Paigen. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 102: 344-352, 1980.
25. Leduc, I., and S. Meloche. Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J. Biol. Chem. 270: 4401-4404, 1995.
26. Martin, M. M., C. R. White, H. Li, P. J. Miller, and T. S. Elton. A functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR). Regul. Pept. 60: 135-147, 1995.
27. Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12: 7035-7056, 1984.
28. Nilsson, J., T. Ksiazek, C. H. Heldin, and J. Thyberg. Demonstration of stimulatory effects of platelet-derived growth factor on cultivated rat arterial smooth muscle cells. Differences between cells from young and adult animals. Exp. Cell Res. 145: 231-237, 1983.
29. Nilsson, J., and J. Thyberg. Fine structure of arterial smooth muscle cells cultured in the presence of whole blood serum or plasma-derived serum. Cell Tissue Res. 223: 87-99, 1982.
30. Owens, G. K. Determinants of angiotensin II-induced hypertrophy versus hyperplasia in vascular smooth muscle. Drug Dev. Res. 29: 83-87, 1993.
31. Pfeifle, B., H. Boeder, and H. Ditschuneit. Interaction of receptors for insulin-like growth factor I, platelet-derived growth factor, and fibroblast growth factor in rat aortic cells. Endocrinology 120: 2251-2258, 1987.
32. Skalli, O., P. Ropraz, A. Trzeciak, G. Benzonana, D. Gillessen, and G. Gabbiani. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 103: 2787-2796, 1986.
33. Wang, J., W. Niu, Y. Nikiforov, S. Naito, S. Chernausek, D. Witte, D. LeRoith, A. Strauch, and J. A. Fagin. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J. Clin. Invest. 100: 1425-1439, 1997.
34. Wang, J., W. Niu, D. P. Witte, S. D. Chernausek, Y. E. Nikiforov, T. L. Clemens, B. Sharifi, A. R. Strauch, and J. A. Fagin. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology 139: 2605-2614, 1998.
35. Ververis, J. J., L. Ku, and P. Delafontaine. Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters. Circ. Res. 72: 1285-1292, 1993.
36. Yamamoto, M., and K. Yamamoto. Growth regulation in primary culture of rabbit arterial smooth muscle cells by platelet-derived growth factor, insulin-like growth factor-I, and epidermal growth factor. Exp. Cell Res. 212: 62-68, 1994.